PREPL: a putative novel oligopeptidase propelled into the limelight

References

Bisceglia, L., Calonge, M.J., Dello Strologo, L., Rizzoni, G., de Sanctis, L., Gallucci, M., Beccia, E., Testar, X., Zorzano, A., Estivill, X., et al. (1996). Molecular analysis of the cystinuria disease gene: identification of four new mutations, one large deletion, and one polymorphism. Hum. Genet.98, 447–451.10.1007/s004390050237Suche in Google Scholar PubMed

Calonge, M.J., Gasparini, P., Chillaron, J., Chillon, M., Gallucci, M., Rousaud, F., Zelante, L., Testar, X., Dallapiccola, B., Di Silverio, F., et al. (1994). Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat. Genet.6, 420–425.10.1038/ng0494-420Suche in Google Scholar PubMed

Font-Llitjos, M., Jimenez-Vidal, M., Bisceglia, L., Di Perna, M., de Sanctis, L., Rousaud, F., Zelante, L., Palacin, M., and Nunes, V. (2005). New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J. Med. Genet.42, 58–68.10.1136/jmg.2004.022244Suche in Google Scholar PubMed PubMed Central

Fulop, V., Bocskei, Z., and Polgar, L. (1998). Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell94, 161–170.10.1016/S0092-8674(00)81416-6Suche in Google Scholar

Fulop, V., Szeltner, Z., and Polgar, L. (2000). Catalysis of serine oligopeptidases is controlled by a gating filter mechanism. EMBO Rep.1, 277–281.10.1093/embo-reports/kvd048Suche in Google Scholar PubMed PubMed Central

Gerczei, T., Keseru, G.M., and Naray-Szabo, G. (2000). Construction of a 3D model of oligopeptidase B, a potential processing enzyme in prokaryotes. J. Mol. Graph. Model.18, 7–17.10.1016/S1093-3263(99)00042-XSuche in Google Scholar PubMed

Jaeken, J., Martens, K., François, I., Eyskens, F., Lecointre, C., Derua, R., Meulemans, S., Slootstra, J., Waelkens, E., De Zegher, F., et al. (2006). Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome. Am. J. Hum. Genet.78, 38–51.10.1086/498852Suche in Google Scholar PubMed PubMed Central

Leung, D., Hardouin, C., Boger, D.L., and Cravatt, B.F. (2003). Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol.21, 687–691.10.1038/nbt826Suche in Google Scholar PubMed

Liu, Y., Patricelli, M.P., and Cravatt, B.F. (1999). Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA96, 14694–14699.10.1073/pnas.96.26.14694Suche in Google Scholar PubMed PubMed Central

Maes, M., Goossens, F., Scharpe, S., Meltzer, H.Y., D'Hondt, P., and Cosyns, P. (1994). Lower serum prolyl endopeptidase enzyme activity in major depression: further evidence that peptidases play a role in the pathophysiology of depression. Biol. Psychiatry35, 545–552.10.1016/0006-3223(94)90101-5Suche in Google Scholar PubMed

Maes, M., Goossens, F., Scharpe, S., Calabrese, J., Desnyder, R., and Meltzer, H.Y. (1995). Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs. Psychiatry Res.58, 217–225.10.1016/0165-1781(95)02698-VSuche in Google Scholar

Mentlein, R. (1988). Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett.234, 251–256.10.1016/0014-5793(88)80092-9Suche in Google Scholar PubMed

Ollis, D.L., Cheah, E., Cygler, M., Dijkstra, B., Frolow, F., Franken, SM., Harel, M., Remington, S.J., Silman, I., Schrag, J., et al. (1992). The ;ga/;gb hydrolase fold. Protein Eng.5, 197–211.10.1093/protein/5.3.197Suche in Google Scholar PubMed

Parvari, R., Brodyansky, I., Elpeleg, O., Moses, S., Landau, D., and Hershkovitz, E. (2001). A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am. J. Hum. Genet.69, 869–875.10.1086/323624Suche in Google Scholar PubMed PubMed Central

Parvari, R., Gonen, Y., Alshafee, I., Buriakovsky, S., Regev, K., and Hershkovitz, E. (2005). The 2p21 deletion syndrome: characterization of the transcription content. Genomics86, 195–211.10.1016/j.ygeno.2005.04.001Suche in Google Scholar PubMed

Polgar, L. (2002). The prolyl oligopeptidase family. Cell. Mol. Life Sci.59, 349–362.10.1007/s00018-002-8427-5Suche in Google Scholar PubMed

Rawlings, N.D. and Barrett, A.J. (1994). Families of serine peptidases. Methods Enzymol.244, 19–61.10.1016/0076-6879(94)44004-2Suche in Google Scholar PubMed PubMed Central

Saadi, I., Chen, X.Z., Hediger, M., Ong, P., Pereira, P., Goodyer, P., and Rozen, R. (1998). Molecular genetics of cystinuria: mutation analysis of SLC3A1 and evidence for another gene in type I (silent) phenotype. Kidney Int.54, 48–55.10.1046/j.1523-1755.1998.00956.xSuche in Google Scholar PubMed

Schulz, I., Gerhartz, B., Neubauer, A., Holloschi, A., Heiser, U., Hafner, M., and Demuth, H.U. (2002). Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition. Eur. J. Biochem.269, 5813–5820.10.1046/j.1432-1033.2002.03297.xSuche in Google Scholar PubMed

Szeltner, Z., Alshafee, I., Juhasz, T., Parvari, R., and Polgar, L. (2005). The PREPL A protein, a new member of the prolyl oligopeptidase family, lacking catalytic activity. Cell. Mol. Life Sci.62, 2376–2381.10.1007/s00018-005-5262-5Suche in Google Scholar PubMed

Turk, B.E. and Cantley, L.C. (2004). Using peptide libraries to identify optimal cleavage motifs for proteolytic enzymes. Methods32, 398–405.10.1016/j.ymeth.2003.10.003Suche in Google Scholar PubMed

Turk, B.E., Huang, L.L., Piro, E.T., and Cantley, L.C. (2001). Determination of protease cleavage site motifs using mixture-based oriented peptide libraries. Nat. Biotechnol.19, 661–667.10.1038/90273Suche in Google Scholar PubMed

Wilk, S. (1983). Prolyl endopeptidase. Life Sci.33, 2149–2157.10.1016/0024-3205(83)90285-0Suche in Google Scholar PubMed

Williams, R.S., Eames, M., Ryves, W.J., Viggars, J., and Harwood, A.J. (1999). Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate. EMBO J.18, 2734–2745.10.1093/emboj/18.10.2734Suche in Google Scholar PubMed PubMed Central

Williams, R.S., Cheng, L., Mudge, A.W., and Harwood, A.J. (2002). A common mechanism of action for three mood-stabilizing drugs. Nature417, 292–295.10.1038/417292aSuche in Google Scholar PubMed

Zaffanello, M., Beghini, R., Zamboni, G., and Fanos, V. (2003). A sporadic case of cystinuria, respiratory chain and growth hormone deficiencies. Pediatr. Nephrol.18, 846–847.10.1007/s00467-003-1189-ySuche in Google Scholar PubMed